Company

Company2019-05-24T14:25:13+00:00
Overview

BiLab revolutionizes cardiopulmonary monitoring with its state-of-the-art technology of electrical impedance tomography (EIT). Noninvasive continuous monitoring of tidal volume and stroke volume is now possible through cross-sectional EIT imaging of the chest.

BiLab’s innovative EIT technology can enhance patient safety and recovery at reduced costs.  Providing pathbreaking solutions to cardiopulmonary monitoring, BiLab supports clinical research to improve patient outcomes using this revolutionary image-based monitoring technology.

History

2019

  • GMP certification from the MFDS in Korea
  • AirTom-R approval from the MFDS in Korea
  • Series A funding from a strategic investor

2018

  • Product design and sample production
  • Animal studies and volunteer studies
  • GMP and medical device approval processes

2017

  • Seed funding from Innopolis Partners
  • Patents transfer from Kyung Hee University
  • Prototype EIT system development
  • Animal studies and clinical studies

2016

  • Founded in July 2016
  • Technology transfer from Impedance Imaging Research Center (IIRC)
People

Founder & acting CTO

Eung Je Woo, Ph.D.

30 years of EIT R&D with
over $15M grants

Chairman of the board

Yongmin Kim, Ph.D.

37 years of medical devices R&D,
former President of POSTECH

CEO

Hun Wi, Ph.D.

12 years of EIT hardware
experience

Product development & manufacturing

Joon Jang

17 years of experience in medical
device product development

Gwang Woo Kong

17 years of experience in medical
device manufacturing

Marketing & sales

Jin Soo Park

30 years of experience in
trading business